Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?

Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI

(2018) Alison D. Sheridan et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience

(2018) Eleonora Di Campli et al.   EUROPEAN JOURNAL OF RADIOLOGY

Magnetic resonance imaging of the prostate at 1.5 versus 3.0 T: A prospective comparison study of image quality

(2017) T. Ullrich et al.   EUROPEAN JOURNAL OF RADIOLOGY

Gadolinium deposition in the brain: summary of evidence and recommendations

(2017) Vikas Gulani et al.   LANCET NEUROLOGY

Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen

(2017) Christiane K. Kuhl et al.   RADIOLOGY

Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2

(2017) Matthew D. Greer et al.   RADIOLOGY

Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable?

(2017) Fabian Steinkohl et al.   WORLD JOURNAL OF UROLOGY

Dynamic contrast-enhanced case-control analysis in 3T MRI of prostate cancer can help to characterize tumor aggressiveness

(2016) Roberto Sanz-Requena et al.   EUROPEAN JOURNAL OF RADIOLOGY

Biparametric 3T Magentic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?

(2016) Arnaldo Stanzione et al.   EUROPEAN JOURNAL OF RADIOLOGY

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

(2016) Jeffrey C. Weinreb et al.   EUROPEAN UROLOGY

Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR

(2016) Andrew B. Rosenkrantz et al.   JOURNAL OF UROLOGY

Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results

(2016) Thomas Auer et al.   WORLD JOURNAL OF UROLOGY

Dynamic Contrast-Enhanced MRI for the Detection of Prostate Cancer: Meta-Analysis

(2015) Cher Heng Tan et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone?

(2015) Barry G. Hansford et al.   RADIOLOGY

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

(2015) Robert J. McDonald et al.   RADIOLOGY

Prostate MRI: Can we do without DCE sequences in 2013?

(2013) P. Puech et al.   Diagnostic and Interventional Imaging

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)

(2012) Gilbert Deray et al.   EUROPEAN RADIOLOGY

ESUR prostate MR guidelines 2012

(2012) Jelle O. Barentsz et al.   EUROPEAN RADIOLOGY

A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens

(2012) Samson W. Fine et al.   EUROPEAN UROLOGY

Immediate Hypersensitivity Reaction to Gadolinium-based MR Contrast Media

(2012) Jae-Woo Jung et al.   RADIOLOGY

Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging

(2010) Nicolas Barry Delongchamps et al.   BJU INTERNATIONAL